Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.110
-0.170 (-13.28%)
At close: Nov 16, 2026, 4:00 PM EST
1.140
+0.030 (2.70%)
After-hours: Nov 16, 2026, 7:58 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $239.45 million as of November 16, 2026. It is the 19,270th most valuable company in the world and the 3,362nd biggest in the United States. Its market cap has increased by 7.68% in one year.
Market Cap
239.45M
Enterprise Value
-36.76M
1-Year Change
7.68%
Global Rank
Country Rank
#3,362 United States
Category
ChartMarket Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $239.45M, an increase of 1.66%. That is a compound annual growth rate of 0.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 239.45M | 13.58% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 255.49M |
| Clinuvel Pharmaceuticals | 254.82M |
| Inovio Pharmaceuticals | 251.50M |
| Q32 Bio | 248.07M |
| Camp4 Therapeutics | 242.23M |
| Rocket Pharmaceuticals | 241.19M |
| Faeth Therapeutics | 239.80M |
| Arcturus Therapeutics Holdings | 239.52M |